BWS
SRPT icon

Buck Wealth Strategies’s Sarepta Therapeutics SRPT Stock Holding History

Buck Wealth Strategies’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36 Buy
+2
New +$38 ﹤0.01% 1164

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Buck Wealth Strategies's SRPT Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 2 shares worth $36. The stake represents ﹤0.01% of the portfolio and ranks #1164 among its holdings.

128 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Buck Wealth Strategies held 2 shares of Sarepta Therapeutics worth $36 as of Q2 2026.
  • Sarepta Therapeutics was a new Buck Wealth Strategies position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1164 holding.
  • 128 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.